Print page

The Global Governance of HIV/AIDS

Intellectual Property and Access to Essential Medicines
Elgar Intellectual Property and Global Development series
Edited by Obijiofor Aginam, Senior Academic Officer, United Nations University Institute for Sustainability and Peace, Tokyo, Japan, John Harrington, Professor of Law, Cardiff University, Wales, UK and Peter K. Yu, Kern Family Chair in Intellectual Property Law, Drake University Law School, US
The Global Governance of HIV/AIDS explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines.
Extent: 304 pp
Hardback Price: £78.00 Online: £70.20
Publication Date: 2013
ISBN: 978 1 84980 490 5
Availability: In Stock
£0.00

Buy the E-book

Join our mailing list

  • Development Studies
  • Development Studies
  • Law and Development
  • Law - Academic
  • Health Law
  • Intellectual Property Law
  • Law and Development
  • Politics and Public Policy
  • International Relations
  • Public Policy
This important book brings together leading scholars from multiple disciplines, including intellectual property, human rights, public health, and development studies, as well as activists to critically reflect on the global health governance regime.

The Global Governance of HIV/AIDS explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines.

This interdisciplinary, global, and up-to-date book will strongly appeal to academics in law, international relations, health policy and public policy, as well as students, policymakers and activists.
‘The different chapters are presented in a coherent manner and are all characterized by a precise yet easy to understand language that makes the book an enjoyable and accessible read for researchers and students alike.’
– Queen Mary Journal of Intellectual Property

‘HIV/AIDS remains a major global health problem, despite the progress made in its prevention and treatment. Addressing this problem is not only a matter of more and better drugs, they need to be widely accessible and be affordable to the poor. This book makes, with a much welcomed interdisciplinary approach, an excellent contribution to understanding how the intellectual property regime can influence health policies and the lives of millions of people affected by the disease. The analysis provided by the various authors that contributed to this book will be of relevance not only to those working in the area of HIV/AIDS, but to those more broadly interested in public health governance and the role of intellectual property rights.’
– Carlos Correa, University of Buenos Aires, Argentina

‘This is an important, innovative and, at times, controversial collection. Inter-disciplinary in approach, this collection will have appeal to those concerned with the global injustice in the context of HIV/AIDS. Investigating the legal, political and economic determinants of access to essential medicines, this is a thought provoking collection which will resonate with many in both the academic and public policy community.’
– Bryan Mercurio, The Chinese University of Hong Kong
Contributors: F.M. Abbott, O. Aginam, T. Amin, L. Biron, A. Denburg, G.E. Evans, J. Harrington, J. Harrison, K. Lee, K.C. Shadlen, P.K. Yu
Contents:

1. Introduction
Obijiofor Aginam and John Harrington

2. Communitarian Globalism and Disease: A Normative Orientation for Global Health Governance
Obijiofor Aginam

3. Is AIDS Treatment Sustainable?
Kenneth C. Shadlen

4. Access to Paediatric Medicines: The Global Political Economy of Drug Production and Supply for Children in the Developing World
Avram Denburg and Kelley Lee

5. Trade Agreements, Intellectual Property and Access to Essential Medicines: What Future Role for the Right to Health?
James Harrison

6. Re-visiting the Patents and Access to Medicines Dichotomy: An Evaluation of TRIPs Implementation and Public Health Safeguards in Developing Countries
Tahir Amin

7. Seizure of Generic Pharmaceuticals in Transit Based on Allegations of Patent Infringement: A Threat to International Trade, Development and Public Welfare
Frederick M. Abbott

8. Patent Licensing Strategies for the Research and Development of Pharmaceuticals in Developing Countries
Gail E. Evans

9. Increasing Access through Incentives for Innovation: The Health Impact Fund
Laura Biron

10. Building IPC4D to Promote Access to Essential Medicines
Peter K. Yu

11. The Global Governance of HIV/AIDS and the Rugged Road Ahead: An Epilogue
Peter K. Yu

Appendices

Index